FDA approves gene-targeting lung cancer drug - BusinessWeek

[INCIID News Feed]

Globe and Mail
<img alt="" height="1" width="1" />
FDA approves gene-targeting lung cancer drug
BusinessWeek
The Food and Drug Administration has approved a new Pfizer drug for a subset of lung cancer patients with a particular genetic mutation. The twice-a-day pill, called Xalkori, is part of a new wave of personalized medications that ...
US FDA approves targeted Pfizer lung cancer drugReuters
FDA Approves New Drug for Advanced NSCLCMedscape
Non-Small Cell Lung Cancer Drug Gets FDA NodMedPage Today
Wall Street Journal -Medical News Today -International Business Times
all 188 news articles &raquo;


More...